|
1
|
Coskun M, Bjerrum JT, Seidelin JB,
Troelsen JT, Olsen J and Nielsen OH: miR-20b, miR-98, miR-125b-1*,
and let-7e* as new potential diagnostic biomarkers in ulcerative
colitis. World J Gastroenterol. 19:4289–4299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeon YJ, Kim OJ, Kim SY, Oh SH, Oh D, Kim
OJ, Shin BS and Kim NK: Association of the miR-146a, miR-149,
miR-196a2, and miR-499 polymorphisms with ischemic stroke and
silent brain infarction risk. Arterioscler Thromb Vasc Biol.
33:420–430. 2013. View Article : Google Scholar
|
|
3
|
Deng S, Zhang Y, Xu C and Ma D:
MicroRNA-125b-2 over-expression represses ectodermal
differentiation of mouse embryonic stem cells. Int J Mol Med.
36:355–362. 2015.PubMed/NCBI
|
|
4
|
Li J, Liang H, Bai M, Ning T, Wang C, Fan
Q, Wang Y, Fu Z, Wang N, Liu R, et al: miR-135b promotes cancer
progression by targeting transforming growth factor beta receptor
II (TGFBR2) in colorectal cancer. PloS One. 10:e01301942015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu L, Zhou X, Qiu MT, Yin R, Wu YQ and Xu
L: Lack of association between hsa-miR-149 rs2292832 polymorphism
and cancer risk: A meta-analysis of 12 studies. PloS One.
8:e737622013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang MW, Jin MJ, Yu YX, Zhang SC, Liu B,
Jiang X, Pan YF, Li QI, Ma SY and Chen K: Associations of
lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene
polymorphisms with gastrointestinal cancer risk. Mol Carcinog.
51(Suppl 1): E21–E31. 2012. View
Article : Google Scholar
|
|
7
|
Chen D, Li Y, Yu Z, Li Y, Su Z, Ni L, Yang
S, Gui Y and Lai Y: Downregulated microRNA-510-5p acts as a tumor
suppressor in renal cell carcinoma. Mol Med Rep. 12:3061–3066.
2015.PubMed/NCBI
|
|
8
|
Tu HF, Liu CJ, Chang CL, Wang PW, Kao SY,
Yang CC, Yu EH, Lin SC and Chang KW: The association between
genetic polymorphism and the processing efficiency of miR-149
affects the prognosis of patients with head and neck squamous cell
carcinoma. PloS One. 7:e516062012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsushita R, Seki N, Chiyomaru T,
Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S,
Itesako T, et al: Tumour-suppressive microRNA-144-5p directly
targets CCNE1/2 as potential prognostic markers in bladder cancer.
Br J Cancer. 113:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY and Lin KH:
MicroRNA-196a/-196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian X, Wei Z, Wang J, Liu P, Qin Y and
Zhong M: MicroRNA-429 inhibits the migration and invasion of colon
cancer cells by targeting PAK6/cofilin signaling. Oncol Rep.
34:707–714. 2015.PubMed/NCBI
|
|
12
|
Luo Z, Zhang L, Li Z, Jiang C, Dai Y, Liu
X, Zheng Y, Yu H, Xiang J and Li G: miR-149 promotes
epithelial-mesenchymal transition and invasion in nasopharyngeal
carcinoma cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 36:604–609.
2011.PubMed/NCBI
|
|
13
|
Øster B, Linnet L, Christensen LL, Thorsen
K, Ongen H, Dermitzakis ET, Sandoval J, Moran S, Esteller M, Hansen
TF, et al: Non-CpG island promoter hypomethylation and miR-149
regulate the expression of SRPX2 in colorectal cancer. Int J
Cancer. 132:2303–2315. 2013. View Article : Google Scholar
|
|
14
|
Vinci S, Gelmini S, Pratesi N, Conti S,
Malentacchi F, Simi L, Pazzagli M and Orlando C: Genetic variants
in miR-146a, miR-149, miR-196a2, miR-499 and their influence on
relative expression in lung cancers. Clin Chem Lab Med.
49:2073–2080. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Santini P, Politi L, Vedova PD, Scandurra
R and Scotto d'Abusco A: The inflammatory circuitry of miR-149 as a
pathological mechanism in osteoarthritis. Rheumatol Int.
34:711–716. 2014. View Article : Google Scholar
|
|
16
|
Ali Sheikh MS, Xia K, Li F, Deng X, Salma
U, Deng H, Wei Wei L, Yang TL and Peng J: Circulating miR-765 and
miR-149: Potential noninvasive diagnostic biomarkers for geriatric
coronary artery disease patients. Biomed Res Int. 2015:7403012015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yim NH, Jung YP, Kim A, Kim T and Ma JY:
Induction of apoptotic cell death by betulin in multidrug-resistant
human renal carcinoma cells. Oncol Rep. 34:1058–1064.
2015.PubMed/NCBI
|
|
18
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong MH, Kim HS, Kim C, Ahn JR, Chon HJ,
Shin SJ, Ahn JB, Chung HC and Rha SY: Treatment outcomes of
sunitinib treatment in advanced renal cell carcinoma patients: A
single cancer center experience in Korea. Cancer Res Treat.
41:67–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao W, Gao Z, Duan Y, Yuan W and Ke Y:
Downregulation of miR-19a exhibits inhibitory effects on metastatic
renal cell carcinoma by targeting PIK3CA and inactivating Notch
signaling in vitro. Oncol Rep. 34:739–746. 2015.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Lu YC, Chang JT, Huang YC, Huang CC, Chen
WH, Lee LY, Huang BS, Chen YJ, Li HF and Cheng AJ: Combined
determination of circulating miR-196a and miR-196b levels produces
high sensitivity and specificity for early detection of oral
cancer. Clin Biochem. 48:115–121. 2015. View Article : Google Scholar
|
|
23
|
Chow TF, Mankaruos M, Scorilas A, Youssef
Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et
al: The miR-17-92 cluster is over expressed in and has an oncogenic
effect on renal cell carcinoma. J Urol. 183:743–751. 2010.
View Article : Google Scholar
|
|
24
|
Maher ER: Genomics and epigenomics of
renal cell carcinoma. Semin Cancer Biol. 23:10–17. 2013. View Article : Google Scholar
|
|
25
|
Ke Y, Zhao W, Xiong J and Cao R: miR-149
inhibits non-small-cell lung cancer cells EMT by targeting FOXM1.
Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang F, Ma YL, Zhang P, Shen TY, Shi CZ,
Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y and Qin HL: SP1
mediates the link between methylation of the tumour suppressor
miR-149 and outcome in colorectal cancer. J Pathol. 229:12–24.
2013. View Article : Google Scholar
|
|
27
|
She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G,
Xiang J, Wu M and Li G: miR-128 and miR-149 enhance the
chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal
remodeling in glioblastoma. Oncol Rep. 32:957–964. 2014.PubMed/NCBI
|
|
28
|
Liu H, Brannon AR, Reddy AR, Alexe G,
Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, et al:
Identifying mRNA targets of microRNA dysregulated in cancer: With
application to clear cell renal cell carcinoma. BMC Syst Biol.
4:512010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He DX, Gu XT, Li YR, Jiang L, Jin J and Ma
X: Methylation-regulated miR-149 modulates chemoresistance by
targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast
cancer. FEBS J. 281:4718–4730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G,
Yang J, Xia L, Wang R, Cai X, Hu H, et al: MicroRNA-149 inhibits
proliferation and cell cycle progression through the targeting of
ZBTB2 in human gastric cancer. PloS One. 7:e416932012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
32
|
Huang GL, Lu Y, Pu XX, He YX, Chen ML, Li
YZ, Tang SY, Che H and He Z: Association study between miR-149 gene
polymorphism and nasopharyngeal carcinoma. Biomed Rep. 1:599–603.
2013.
|
|
33
|
Wei WJ, Lu ZW, Li DS, Wang Y, Zhu YX, Wang
ZY, Wu Y, Wang YL and Ji QH: Association of the miR-149 Rs2292832
polymorphism with papillary thyroid cancer risk and
clinicopathologic characteristics in a Chinese population. Int J
Mol Sci. 15:20968–20981. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu L and Tang W: The associations of
nucleotide polymorphisms in mir-196a2, mir-146a, mir-149 with lung
cancer risk. Cancer Biomark. 15:57–63. 2015.
|
|
35
|
Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu
H, Liu H, Chen B, Li Q, Ma X and Chen K: Associations of miRNA
polymorphisms and female physiological characteristics with breast
cancer risk in Chinese population. Eur J Cancer Care (Engl).
21:274–280. 2012. View Article : Google Scholar
|
|
36
|
Ding SL, Wang JX, Jiao JQ, Tu X, Wang Q,
Liu F, Li Q, Gao J, Zhou QY, Gu DF and Li PF: A pre-microRNA-149
(miR-149) genetic variation affects miR-149 maturation and its
ability to regulate the Puma protein in apoptosis. J Biol Chem.
288:26865–26877. 2013. View Article : Google Scholar : PubMed/NCBI
|
